Ingen internetforbindelse — viser den gemte version af siden.

Quest Diagnostics…

USUSD
← Til screeneren

Quest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
questdiagnostics.com
Investorrelationer
ir.questdiagnostics.com/overview/default.aspx
Sektor
Health Care · Medical Specialities
Hovedkontor
Madison, United States
Administrerende direktør
Steve Rusckowski
Ansatte
46 000
Grundlagt
1967
Børsnoteret siden
29.01.2018 (LSE:0KSX)
Udestående aktier
110.37 mio. pr. 2026-07-15
Free float
109.81 mio.
Markedsværdi
25.21 mia. USD
Insidere
0.43%
Institutionelle investorer
98.9%
Branche (SIC)
Services-Medical Laboratories
LEI
8MCWUBXQ0WE04KMXBX50
Udbetalingsgrad
34.2%
FCF
1.35 mia. USD
27%
Gæld
6.38 mia. USD
3.7 år FCF
Udbyttestreak
22 år
Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 30.06.2026 (selskabets seneste rapport).
Beskrivelse

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksDGX primærUSD230.81 +1.65%almindelige aktier
LSE London Stock Exchange0KSX IOBUSD231.43 +0.00%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

De sidste 12 måneder, US:DGX: 3.38 USD (4 udb.)

Quest Diagnostics Incorporated (DGX) udbetaler udbytte kvartalsvis. I løbet af de sidste 12 måneder blev der betalt 3.38 USD pr. Aktie (betalinger: 4). Det svarer til cirka 1.46% af den nuværende aktiekurs. Baseret på betalingshistorikken forventes næste ex-udbyttedato omkring 05.01.2027. Uafbrudt udbyttehistorik: 22 år.

Ex-datoUdbetalingBeløb%TypeTicker
2026-10-062026-10-210.8600 USD0.4/1.5 %kvartalsvisUS:DGX
2026-07-082026-07-220.8600 USD0.4/1.4 %kvartalsvisUS:DGX
2026-04-062026-04-200.8600 USD0.4/1.4 %kvartalsvisUS:DGX
2026-01-132026-01-280.8000 USD0.3/1.4 %kvartalsvisUS:DGX
2025-10-032025-10-200.8000 USD0.3/≈1.4 %kvartalsvisUS:DGX
2025-07-072025-07-210.8000 USD0.3/≈1.4 %kvartalsvisUS:DGX
2025-04-072025-04-210.8000 USD0.3/≈1.4 %kvartalsvisUS:DGX

Nyheder denne uge

Endnu ingen nyheder fra virksomhedens websted.

annonce

Største ejere

EjerAndelAktierRapportdato
Blackrock Inc.8.4%9.28 mio.2026-06-30
Vanguard Capital Managem…6.55%7.23 mio.2026-06-30
Vanguard Portfolio Manag…5.55%6.13 mio.2026-06-30
State Street Corporation5%5.52 mio.2026-06-30
Price (T.Rowe) Associate…4.93%5.44 mio.2026-06-30
Boston Partners4.3%4.74 mio.2026-06-30
JPMORGAN CHASE & CO3.19%3.52 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.51 mio.2026-06-30
Geode Capital Management…2.84%3.14 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.6%2.87 mio.2026-06-30
Morgan Stanley2.23%2.46 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.17%2.4 mio.2026-06-30
Edgepoint Investment Gro…2.04%2.25 mio.2026-06-30
iShares Trust-iShares Co…1.33%1.47 mio.2026-08-31
Fidelity Concord Street…1.3%1.43 mio.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%1.36 mio.2026-08-31
John Hancock Funds III-D…1.09%1.2 mio.2026-07-31
JPMorgan Trust II-JPMorg…1.04%1.15 mio.2026-06-30
T. Rowe Price Dividend G…1%1.11 mio.2026-06-30
John Hancock Funds III-D…0.96%1.06 mio.2026-07-31
DAVIS J E CAUSEY (Chief…≈0.13%142 4232026-03-04
DAVIS JAMES E (Chief Exe…≈0.11%122 4232026-09-01
DOHERTY CATHERINE T (Off…≈0.06%71 6242026-03-05
PREVOZNIK MICHAEL E (Gen…≈0.04%42 3372026-08-28
DEPPE MICHAEL J (Officer…≈0.03%35 1962026-03-04
SAMAD SAMER ABDUL (Chief…≈0.03%33 4782026-07-22
RING TIMOTHY M (Director…≈0.03%31 1402026-05-20
PFEIFFER GARY M (Directo…≈0.03%31 0052026-05-20
MAIN TIMOTHY L (Director…≈0.02%27 4602026-07-22
GREGG VICKY B (Director)≈0.02%18 3862026-07-22